Literature DB >> 1445122

Jaundice: clinical practice in 88,000 liveborn infants.

R L Guaran1, J H Drew, A M Watkins.   

Abstract

We reviewed jaundiced infants born between 1971 and 1989. Jaundice was diagnosed in infants whose serum bilirubin level was found to be 154 umol/l or greater. Of 88,137 livebirths, 10,944 (12.4%) were jaundiced. The most common aetiological factor was prematurity (20.3%), followed by ABO erythroblastosis (5.5%), sepsis (1.8%), Rh erythroblastosis (1.8%), bruising (1.3%), multifactorial (1.0%) and glucose-6-phosphate dehydrogenase deficiency (0.5%). In the remainder (67.8%) no cause was found or inadequate investigations were performed to determine a cause. During the period under review there was a significant increase (r = 0.91) in the proportion of newborn infants with jaundice of prematurity, in those not investigated (r = 0.92) and a decrease in the proportion with bruising (r = -0.90) as the cause. Phototherapy was used on 4,126 (37.7%) infants and exchange transfusion performed on 248 (2.3%). Causes of jaundice in infants requiring exchange transfusion were Rh erythroblastosis (108, 43.6%), ABO erythroblastosis (58, 23.4%), jaundice of prematurity (44, 17.7%) and a variety of causes in the remaining 38 (15.3%). Death occurred in 164 (1.5%) infants. In only 7 (4.3%), however, was the death possibly related to hyperbilirubinaemia or its treatment (Rh erythroblastosis (4), necrotizing enterocolitis following exchange transfusion (2) and pulmonary haemorrhage following exchange transfusion (1)). Phototherapy proved safe with no deaths attributable to its use.

Entities:  

Mesh:

Year:  1992        PMID: 1445122     DOI: 10.1111/j.1479-828x.1992.tb01942.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  7 in total

1.  Cloning and overexpression of rat kidney biliverdin IX alpha reductase as a fusion protein with glutathione S-transferase: stereochemistry of NADH oxidation and evidence that the presence of the glutathione S-transferase domain does not effect BVR-A activity.

Authors:  O Ennis; R Maytum; T J Mantle
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

2.  Neonatal hyperbilirubinemia and its association with thyroid hormone levels and urinary iodine excretion.

Authors:  B Singh; R Ezhilarasan; P Kumar; A Narang
Journal:  Indian J Pediatr       Date:  2003-04       Impact factor: 1.967

3.  Infantile pyknocytosis, a rare cause of hemolytic anemia in newborns: report of two cases in twin girls and literature overview.

Authors:  Mohamad El Nabouch; Iarolalao Rakotoharinandrasana; Alexis Ndayikeza; Véronique Picard; Simon Kayemba-Kay's
Journal:  Clin Case Rep       Date:  2015-05-08

Review 4.  Yinzhihuang oral liquid in the treatment of neonatal jaundice: a meta-analysis.

Authors:  Jie Zeng; Su-Jun Wang; Yong-Mei Li; Hang-Shan Li; Qian Luo; Yun-Ying Huang; Qun Jiang; Li Wang
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 5.  Immunoglobulin for alloimmune hemolytic disease in neonates.

Authors:  Carolien Zwiers; Mirjam Ea Scheffer-Rath; Enrico Lopriore; Masja de Haas; Helen G Liley
Journal:  Cochrane Database Syst Rev       Date:  2018-03-18

6.  Evaluation of risk factors for development of severe hyperbilirubinemia in term and near term infants in Turkey.

Authors:  Ali Bulbul; Nihal Cayonu; Merve Emecen Sanli; Sinan Uslu
Journal:  Pak J Med Sci       Date:  2014-09       Impact factor: 1.088

7.  Evaluation of a simple intervention to reduce exchange transfusion rates among inborn and outborn neonates in Myanmar, comparing pre- and post-intervention rates.

Authors:  G Arnolda; A A Thein; D Trevisanuto; N Aung; H M Nwe; A A Thin; N S S Aye; T Defechereux; D Kumara; L Moccia
Journal:  BMC Pediatr       Date:  2015-12-17       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.